Tofacitinib for the treatment of moderate-to-severe psoriasis.
about
Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasisType I/II cytokines, JAKs, and new strategies for treating autoimmune diseasesUpdates on Psoriasis and Cutaneous Oncology: Proceedings from the 2015 MauiDerm MeetingNecroinflammation in Kidney Disease.Small molecules and antibodies for the treatment of psoriasis: a patent review (2010-2015).JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.Tofacitinib: A New Oral Therapy for Psoriasis.JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.Oral Tofacitinib for the Treatment of Adults with Moderate to Severe Chronic Plaque Psoriasis.
P2860
Q26765028-A1F1D3B8-F58C-4D0D-9AB1-77F4AC71E168Q26775111-99006690-23FD-4D9A-B62C-0D7A2DACAD58Q35822379-5338B730-8269-41BB-A5FD-690AF611F22FQ38579499-0791742A-7580-43AA-89E2-EA31DCE2C642Q38856226-CB4EA438-C182-4C20-A167-3B026FD9B054Q47439880-17CEA40E-3709-44EF-8C1D-C9443336558BQ47623085-38E88525-19A8-4C9A-B2A1-F872A2224F4AQ48556502-4B9B7398-6E72-48FC-8568-BF975FA8577EQ54214722-C28BB0B3-3C4B-46AC-BD46-A0D4331D971F
P2860
Tofacitinib for the treatment of moderate-to-severe psoriasis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Tofacitinib for the treatment of moderate-to-severe psoriasis.
@en
type
label
Tofacitinib for the treatment of moderate-to-severe psoriasis.
@en
prefLabel
Tofacitinib for the treatment of moderate-to-severe psoriasis.
@en
P2093
P2860
P1476
Tofacitinib for the treatment of moderate-to-severe psoriasis.
@en
P2093
Andrea Chiricozzi
Luca Bianchi
Oreste Buonomo
Rosita Saraceno
Sara Faleri
Sergio Chimenti
P2860
P304
P356
10.1586/1744666X.2015.1013534
P577
2015-02-10T00:00:00Z